News in the Life Sciences Industry

TAIPEI, Taiwan, May 20, 2020 /PRNewswire/ -- OBI Pharma, Inc. (TPEx: 4174), a leader in Glycosphingolipid Immuno-Oncology therapeutics targeting the Globo Series antigens (Globo H and SSEA-4) and chemotherapeutics targeting AKR1C3, today announced that data highlighting the ongoing clinical... Read more ››

STOCKHOLM, May 20, 2020 /PRNewswire/ -- OrtoWay AB, makers of the OrtoWell(®) Distractor - the world's first hydraulically powered device for spinal surgery - today announces new tool design improvements extending the clinical usage. It has also formed a new subsidiary and established manufacturing... Read more ››

LUND, Sweden, May 20, 2020 /PRNewswire/ -- Hansa Biopharma, the leader in immunomodulatory enzyme technology for rare IgG mediated diseases, today announced that the Company's novel IgG-degrading enzyme, imlifidase, will be highlighted in three presentations including a late breaking poster presentation... Read more ››

LUND, Sweden, May 20, 2020 /PRNewswire/ -- Hansa Biopharma AB (publ), Reg. No. 556734-5359, with registered office in Lund, summons to Annual General Meeting on Tuesday June 23, 2020 at 15:00 CEST at the Elite Hotel Ideon, Scheelevägen 27, SE-223 63 Lund, Sweden. Registration will begin... Read more ››

STOCKHOLM, May 20, 2020 /PRNewswire/ -- Cyxone (publ), a Swedish biotech in autoimmune diseases, announces today that Tara Heitner PhD MBA has been appointed new CEO for the company by Board of Directors.

UPPSALA, Sweden, May 19, 2020 /PRNewswire/ -- Today on 19 May 2020, Orexo AB (publ) held an extraordinary general meeting. The extraordinary general meeting passed the following resolutions.

STOCKHOLM, May 19, 2020 /PRNewswire/ -- IRRAS AB (publ) ("IRRAS", or the "Company") announces that Nasdaq Stockholm's listing committee has approved the Company for listing on Nasdaq Stockholm's main list. In connection with the list change from Nasdaq First North Premier Growth Market to... Read more ››

- Radiopharmaceutical company brings leading Nordic life science investor onboard

STOCKHOLM, May 19, 2020 /PRNewswire/ -- The European Patent Office has granted Enzymatica's patent for the key cod enzyme component of Enzymatica's cold spray ColdZyme(®) for the European market. The patent is valid until 2035. Enzymatica has also filed corresponding patent application for... Read more ››

VIST(®) G7 Brings Reality to Complex Interventions and Introduces a Scalable and Flexible Platform for Advanced Future Applications